SPS
IGMS

Susquehanna Portfolio Strategies’s IGM Biosciences IGMS Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14,385
Closed -$87.9K – 165
2024
Q4 		$87.9K Sell
14,385
-15,824
-52% -$188K 0.3% 15
2024
Q3 		$500K Hold
30,209
– – 0.03% 246
2024
Q2 		$208K Hold
30,209
– – 0.01% 461
2024
Q1 		$292K Hold
30,209
– – 0.01% 672
2023
Q4 		$251K Buy
+30,209
New +$175K ﹤0.01% 897

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Susquehanna Portfolio Strategies's IGMS Position: Q1 2025 in Review

Susquehanna Portfolio Strategies sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 14,385 shares — an estimated $87.9K sold.

Susquehanna Portfolio Strategies first reported a position in IGMS in Q4 2023 and held it in 5 quarters. The position peaked at $500K in Q3 2024. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

  • Susquehanna Portfolio Strategies reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 14,385 IGM Biosciences shares in Q1 2025, an estimated $87.9K.
  • Susquehanna Portfolio Strategies first reported a position in IGM Biosciences in Q4 2023 and held it in 5 quarters.
  • Susquehanna Portfolio Strategies's IGM Biosciences position peaked at $500K in Q3 2024.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2025, filed 14 May 2025.